|
|
Advertisement |
 |
|
|
Advertisement |
Watch this brief video to learn how analytics can help your product access program.
Learn more |
|
|
|
Advertisement |
 |
|
|
Advertisement |
Breaking the Circle of Distrust with a Radical PLC Pricing Model
On Demand
Learn more |
|
Advertisement |
Best Practices for Integrating Biomarkers
across the Drug Development Continuum
On Demand
Learn more |
|
|
Industry update |
//Bristol-Myers Squibb (New York, NY) appointed Fouad Namouni, M.D. as Oncology Development Head.//Syndax Pharmaceuticals, Inc. (Waltham, MA) announced the appointment of seven oncology experts to its Scientific Advisory Board (SAB): Ronald M. Evans, Ph.D; Julie R. Brahmer, M.D.; Joseph Paul Eder, M.D.; Rachel Humphrey, M.D.; Samir Khleif, M.D.; Hope S. Rugo, M.D.; and Jedd D. Wolchok, M.D., Ph.D.// |
|
|
|
|
|